Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) has awarded biopharmaceutical company Anthera Pharmaceuticals, Inc. a $3 million grant to help accelerate the development and clinical study of the company’s new pancreatic enzyme replacement therapy. The investigative therapeutic option called Sollpura (liprotamase) is ... Read more